Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
21,72 USD | -3,21 % | -7,18 % | -27,53 % |
Kurzporträt
Mitarbeiterzahl: 268
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 04.01.18 |
Kinnari Patel
PSD | President | 46 | 04.01.18 |
Chief Tech/Sci/R&D Officer | 60 | 01.01.16 | |
Mayo Pujols
CTO | Chief Tech/Sci/R&D Officer | 55 | 27.07.22 |
David Southwell
BRD | Director/Board Member | 63 | 01.08.14 |
Brooks Rahmer
IRC | Investor Relations Contact | - | - |
Mark White
PRN | Corporate Officer/Principal | 57 | 04.04.23 |
Carlos Martin
PRN | Corporate Officer/Principal | - | - |
Isabel Carmona
HRO | Human Resources Officer | - | 07.09.21 |
Gayatri R. Rao
PRN | Corporate Officer/Principal | - | 01.05.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 04.01.18 |
Carsten Boess
BRD | Director/Board Member | 57 | 01.01.16 |
David Southwell
BRD | Director/Board Member | 63 | 01.08.14 |
Rod Wong
CHM | Chairman | 47 | 01.01.18 |
Director/Board Member | 47 | 01.01.18 | |
Gotham Makker
BRD | Director/Board Member | 50 | 04.01.18 |
Fady Malik
BRD | Director/Board Member | 59 | 10.03.22 |
Director/Board Member | 63 | 20.04.20 | |
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 04.01.18 |
R. Woods
BRD | Director/Board Member | 57 | 12.12. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 90 782 211 | 85 857 306 ( 94,58 %) | 0 | 94,58 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-27,29 % | 2,04 Mrd. | |
+10,37 % | 115 Mrd. | |
+12,31 % | 106 Mrd. | |
-5,37 % | 24,69 Mrd. | |
-1,25 % | 21,97 Mrd. | |
-4,78 % | 19,27 Mrd. | |
-11,93 % | 17,56 Mrd. | |
-39,36 % | 17,32 Mrd. | |
+5,79 % | 14,03 Mrd. | |
+33,11 % | 12,13 Mrd. |
- Börse
- Aktien
- A2JA9Q Aktie
- Unternehmen Rocket Pharmaceuticals, Inc.